Stock Market News

4 weeks Craig Hallum Raises Eton Pharmaceuticals (NASDAQ:ETON) Price Target to $15.00MarketBeat

Craig Hallum raised their price target on shares of Eton Pharmaceuticals from $10.00 to $15.00 and gave the stock a “buy” rating in a research report on Monday.

Nasdaq 100 · Pharmaceuticals · Science

16 mins Could Serve Robotics Become the Next Nvidia?The Motley Fool X

2 hours Want Better Habits? Neuroscience Says This Is How to Train Your BrainInc.com X

3 hours Argus Raises NVIDIA Corporation (NVDA) Price Target to $175, Citing Strong Q3 Performance and Growth Across Multiple MarketsInsider Monkey X

3 hours QUALCOMM Incorporated (QCOM) to Launch Affordable Snapdragon X Chip, Expanding AI-Powered Windows Laptop MarketInsider Monkey X

3 hours KeyBanc Raises CrowdStrike Holdings, Inc. (CRWD) Price Target to $395, Highlights Strong Results and AI-Driven Cybersecurity StrengthInsider Monkey X

3 hours JMP Securities Lifts DocuSign, Inc. (DOCU) Price Target to $108, Highlights Positive Sales Momentum and AI InnovationsInsider Monkey X

5 hours JMP Securities Raises BlackLine, Inc. (BL) Price Target to $86, Highlights $45B Market OpportunityInsider Monkey X

5 hours Equinix, Inc. (EQIX) Price Target Raised to $975 by Argus on Strong Growth Prospects and Positive MomentumInsider Monkey X

5 hours Advanced Micro Devices, Inc. (AMD) Set to Expand AI Portfolio with Affordable Krackan Point Processor LeakInsider Monkey X

6 hours Meta Platforms, Inc. (META) Advances Plans for $10 Billion AI Data Center in LouisianaInsider Monkey X

8 hours Amazon.com, Inc. (AMZN) Faces Potential EU Antitrust Investigation Over Marketplace Practices, Could Face Hefty FinesInsider Monkey X

8 hours Microsoft Corporation (MSFT) Unveils New AI Products and Features at Ignite, CEO Satya Nadella Highlights Rapid AI Investment GrowthInsider Monkey X

8 hours Alphabet Inc. (GOOG) Partners with Rezolve AI to Enhance Conversational Commerce SolutionsInsider Monkey X

8 hours Cadence (CDNS) Unveils First Arm-Based Chiplet: Boosting AI Efficiency and PowerInsider Monkey X

8 hours Fortinet, Inc (FTNT) and Skylark Launch AI-Powered Cybersecurity Centre in ChennaiInsider Monkey X

8 hours GlobalFoundries (GFS) Faces Market Oversupply: UBS Initiates Neutral RatingInsider Monkey X

8 hours QUALCOMM Incorporated (QCOM) CEO Cristiano Amon Dismisses Rumors of Intel Acquisition Amid AI Expansion into Cars and IoTInsider Monkey X

8 hours NVIDIA Corporation (NVDA) Beats Expectations with 70% YoY Revenue Growth and Strong AI Enterprise Demand, Citi Analyst SaysInsider Monkey X

9 hours FIFA, Mythical Games collaborate to launch blockchain game FIFA RivalsCointelegraph X

11 hours Lucid Is Shifting Into Higher Gear. Is the Stock a Buy Now?The Motley Fool X

11 hours 3 Dividend Stocks to Double Up on Right NowThe Motley Fool X

11 hours This Might Just Be Rivian’s Best Decision YetThe Motley Fool X

12 hours Is CrowdStrike Holdings a Buy?The Motley Fool X

12 hours Is Buying Airbnb Stock Below $135 a Smart Idea?The Motley Fool X

13 hours Can Anything Stop Nvidia?The Motley Fool X

13 hours Could Buying Apple Stock Today Set You Up for Life?The Motley Fool X

15 hours Should You Buy PayPal Stock While It’s Below $87?The Motley Fool X

15 hours Should You Buy PayPal Stock While It’s Below $87?The Motley Fool X

17 hours Got $1,500? Buy Iovance Biotherapeutics Now and Don’t Look BackThe Motley Fool X

17 hours Got $1,500? Buy Iovance Biotherapeutics Now and Don’t Look BackThe Motley Fool X

18 hours Supermicro Shares Soar as It Looks to Avoid Being Delisted. Is Now a Good Time to Buy the Beaten-Down Stock?The Motley Fool X

18 hours Supermicro Shares Soar as It Looks to Avoid Being Delisted. Is Now a Good Time to Buy the Beaten-Down Stock?The Motley Fool X

18 hours Advanced Micro Devices, Inc. (AMD) CEO Lisa Su Advocates for Open-Source AI Ecosystem and Holistic Data Center Design in IndiaInsider Monkey X

18 hours This 1 Investing Rule From Warren Buffett Could Supercharge (or Sink) Your PortfolioThe Motley Fool X

18 hours This 1 Investing Rule From Warren Buffett Could Supercharge (or Sink) Your PortfolioThe Motley Fool X

18 hours Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

18 hours Merus NV (MRUS): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

18 hours Nvidia Stock Investors Can Expect Revenue and Profit to Rise FurtherThe Motley Fool X

18 hours Nvidia Stock Investors Can Expect Revenue and Profit to Rise FurtherThe Motley Fool X

18 hours Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

18 hours Moderna Inc. (MRNA): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

18 hours Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

18 hours Guardant Health, Inc. (GH): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

18 hours Tango Therapeutics Inc. (TNGX): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

18 hours So Many Days Lost at the Doctor’s OfficeThe New York Times X

18 hours Immunitybio Inc. (IBRX): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X

18 hours AstraZeneca (AZN): A Top Pick for Hedge Funds Due to Innovation and Rising DemandInsider Monkey X

19 hours ON Semiconductor (ON) Initiated at Overweight by Wells Fargo with $85 Target, Highlighting Gen-AI and EV Growth OpportunitiesInsider Monkey X

19 hours Arm Holdings (ARM) Set for Growth as Wells Fargo Targets $155 with Overweight RatingInsider Monkey X

19 hours Clean Energy Fuels Corp. (CLNE): Analysts Are Bullish On This Oil and Gas Stock NowInsider Monkey X